Engineers Gate Manager LP Ovid Therapeutics Inc. Transaction History

Engineers Gate Manager LP

  • $3.68 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.31 - $4.04 $41,537 - $50,697
-12,549 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$3.3 - $4.49 $41,411 - $56,345
12,549 New
12,549 $49,000
Q1 2021

May 17, 2021
SELL
$2.42 - $4.47 $31,460 - $58,110
-13,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$2.28 - $6.84 $23,939 - $71,820
-10,500 Reduced 44.68%
13,000 $30,000
Q3 2020

Nov 16, 2020
BUY
$5.39 - $8.24 $126,664 - $193,640
23,500 New
23,500 $135,000

Others Institutions Holding OVID

# of Institutions
82
Shares Held
43.2M
Call Options Held
5.9K
Put Options Held
300
View Full List

About Ovid Therapeutics Inc.

OVID Quotes by TradingView
  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $52.8M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email